Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1986
Report date:
1986

Materials and methods

Objective of study:
absorption
excretion
Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 417 (Toxicokinetics)
Principles of method if other than guideline:
The radioactively labelled compound was applied as a single oral dose (appr. 10 mg/kg body weight) to three female rats. The intestinal absorption was studied for 96 hours after application.
GLP compliance:
not specified

Test material

Constituent 1
Reference substance name:
Imidazolium compounds, 2-(C15-17(odd numbered), C17-unsatd. alkyl)-1-[2-(C16-18(even numbered), C18-unsatd. amido)ethyl]-4,5-dihydro-N-methyl, Me sulfates)
IUPAC Name:
Imidazolium compounds, 2-(C15-17(odd numbered), C17-unsatd. alkyl)-1-[2-(C16-18(even numbered), C18-unsatd. amido)ethyl]-4,5-dihydro-N-methyl, Me sulfates)
Radiolabelling:
yes
Remarks:
labelled at the C-atom in the N-methyl-group of the imidazolinium-ring, specific activity 2.55 mCi/mMol

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Fa. Winkelmann, Borchen
- Weight at study initiation: 220 g - 235 g
- Housing: individually in metabolism cages
- Diet (e.g. ad libitum): Altromin 1324, ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 d


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20°C
- Fasting period: 24 h



Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on exposure:
PREPARATION OF DOSING SOLUTIONS:
444.7 mg test item (50% solution) was dissolved in 99.114 g bidestilled water, resulting in 2.23 mg test item/g solution
approx. 1 g of this solution was administered to the animals, corresponding to 9.115±0.39 mg/kg bw

Doses / concentrations
Dose / conc.:
10 mg/kg bw/day
No. of animals per sex per dose / concentration:
3
Control animals:
no
Details on dosing and sampling:
TOXICOKINETIC / PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled: urine, faeces, expired air, cage washes, gastro intestinal tract, carcass
- Time and frequency of sampling:
Urine: 0 - 8 h; 8 - 24 h; 24 - 48 h; 48 - 72 h; 72 - 96 h
faeces: 0 - 24 h; 24 - 48 h; 48 - 72 h; 72 - 96 h
expired air: 0 - 8 h; 8 - 24 h; 24 - 48 h; 48 - 72 h; 72 - 96 h
cage wash: after 96 h




Results and discussion

Main ADME resultsopen allclose all
Type:
absorption
Results:
at least 0.792%
Type:
excretion
Results:
urine: 0.524
faeces: 78.7%
Type:
distribution
Results:
gastrointestinal tract: 0.077%
carcass: below detection limit

Toxicokinetic / pharmacokinetic studies

Details on absorption:
An intestinal absorption of at least 0.792 % of the administered dose was found.
Details on excretion:
0.407% of the applied dose was excreted in the urine within 24 hrs after application, 0.221% within the first 8 hrs.
In the faeces 78.7% of the adminstered radioactivity was eliminated within 96 hrs, 54.9% of the adminstered radioactivity within the first 24 hours. Hence it follows that either a great part of the applied substance was not absorbed intestinally or a part was eliminated by biliary excretion after intestinal absorption.

Metabolite characterisation studies

Metabolites identified:
no

Applicant's summary and conclusion

Executive summary:

(N-methyl-14C)-imidazoliniumquat-methosulfate was used for this study. The compound was labelled at the C-atom in the N-methyl-group of the imidazolinium-
ring. The radioactive compound was applied as a single oral dose (appr. 10 mg/kg body weight). Three female rats (SPF-Cpb) were used as a test group (mean body weight: 227 ± 7 g). The intestinal absorption was studied for 96 hours after application.
An intestinal absorption of at least 0.792 % of the administered dose was found.
0.407% of the applied dose was excreted in the urine within 24 hrs after application, 0.221% within the first 8 hrs.
In the faeces 78.7% of the adminstered radioactivity was eliminated within 96 hrs, 54.9% of the adminstered radioactivity within the first 24 hours. Hence it follows that either a great part of the applied substance was not absorbed intestinally or a part was eliminated by biliary excretion after intestinal absorption.
The radioactivity found in the expired air (measured with all rats) was below the detection limit.
Also, the radioactivity found in the carcass 96 hours after application was below the detection limit (except one animal).